Clinical Trial Flexibility and Customization Needs that are Required by Biotechs and Next Generation Therapies
Join Catalyst Oncology's Vice President of Oncology Drug Development, Andrew Zupnick, PhD, our Executive Director of Oncology Drug Development, Susan Albert, alongside X4 Pharmaceuticals' Senior Vice President of Development Operations, Carrie Melvin, and Medidata Solutions' Senior Director, Ted Kirby, in this DIA-hosted webinar to hear how we implement our core value of flexibility into your clinical trials.
3 December 2020 | 11:00 AM - 12:00 PM ET
The 62 annual ASH meeting exposition will take place this virtually year in light of health concerns and travel restrictions. Catalyst will be exhibiting at the premier event in malignant and non-malignant hematology. We look forward to connecting with you at the world’s most comprehensive hematology event of the year, and welcome the opportunity to learn invaluable information and gain priceless experience at the 62 annual meeting. For more information on ASH, or to schedule a meeting with Catalyst, click the buttons below.
5 - 8 December 2020